Pharmacobezoars described and demystified

References

• Andrus CH, Ponsky JL. Bezoars: classification, pathophysiology, and treatment. Am J Gastroenterol 1988; 83:476–478.
   PubMed Web of Science ®Google Scholar
• Watson WA, Cremer KF, Chapman JA. Gastrointestinal obstruction associated with multiple-dose activated charcoal. J Emerg Med 1986; 4:401–407.
   PubMedGoogle Scholar
• Ray MJ, Radin DR, Condie JD, Halls JM. Charcoal bezoar. Small-bowel obstruction secondary to amitriptyline overdose therapy. Dig Dis Sci 1988; 33:106–107.
   PubMed Web of Science ®Google Scholar
• Atkinson SW, Young Y, Trotter GA. Treatment with activated charcoal complicated by gastrointestinal obstruction requiring surgery. BMJ 1992; 305:563.
   PubMed Web of Science ®Google Scholar
• Merriman T, Stokes K. Small bowel obstruction secondary to administration of activated charcoal. Aust N Z J Surg 1995; 65:288–289.
   PubMedGoogle Scholar
• Gomez HF, Brent JA, Munoz DC 4th, Mimmack RF, Ritvo J, Phillips S, McKinney P. Charcoal stercolith with intestinal perforation in a patient treated for amitriptyline ingestion. J Emerg Med 1994; 12:57–60.
   PubMedGoogle Scholar
• Mizutani T, Naito H, Oohashi N. Rectal ulcer with massive haemorrhage due to activated charcoal treatment in oral organophosphate poisoning. Hum Exp Toxicol 1991; 10:385–386.
   PubMed Web of Science ®Google Scholar
• Goulbourne KB, Cisek JE. Small-bowel obstruction secondary to activated charcoal and adhesions. Ann Emerg Med 1994; 24:108–110.
   PubMed Web of Science ®Google Scholar
• Mauro LS, Nawarskas JJ, Mauro VF. Misadventures with activated charcoal and recommendations for safe use. Ann Pharmacother 1994; 28:915–924.
   PubMed Web of Science ®Google Scholar
• Flores F, Battle WS. Intestinal obstruction secondary to activated charcoal. Contemp Surg 1987; 30:57–59.
   Google Scholar
• Chan JC, Saranasuriya C, Waxman BP. Bezoar causing small bowel obstruction after repeated activated charcoal administration. Med J Aust 2005; 183:537.
   PubMed Web of Science ®Google Scholar
• Dorrington CL, Johnson DW, Brant R; for the MDAC Study Group. The frequency of complications associated with the use of multiple-dose activated charcoal. Ann Emerg Med 2003; 41:370–377.
   PubMed Web of Science ®Google Scholar
• Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1999; 37:731–751.
   PubMed Web of Science ®Google Scholar
• Havens W. Intestinal obstruction caused by colloidal aluminum hydroxide. JAMA 1939; 113:1564–1565.
   Google Scholar
• Townsend CM Jr, Remmers AR Jr, Sarles HE, Fish JC. Intestinal obstruction from medication bezoar in patients with renal failure. N Engl J Med 1973; 288:1058–1059.
   PubMed Web of Science ®Google Scholar
• Korenman MD, Stubbs MB, Fish JC. Intestinal obstruction from medication bezoars. JAMA 1978; 240:54–55.
   PubMed Web of Science ®Google Scholar
• Girotti MJ, Ruddan J, Cohanim M. Amphojeloma: antacid impaction in a critically ill patient. Can J Surg 1984; 27:379–380, 382.
   PubMed Web of Science ®Google Scholar
• Potyk D. Intestinal obstruction from impacted antacid tablets. N Engl J Med 1970; 283:134–135.
   PubMed Web of Science ®Google Scholar
• Burruss GL, Van Voorst SJ, Crawford AJ, et al. Small bowel obstruction from an antacid bezoar: a ranitidine-antacid interaction? South Med J 1986; 79:917–918.
   PubMed Web of Science ®Google Scholar
• Portuguez-Malavasi A, Aranda JV. Antacid bezoar in a newborn. Pediatrics 1979; 63:679–680.
   PubMed Web of Science ®Google Scholar
• Baum J. Enteric coated aspirin today. J Rheumatol 1985; 12:829–832.
   PubMed Web of Science ®Google Scholar
• Harris FC. Pyloric stenosis: hold-up of enteric coated aspirin tablets. Br J Surg 1973; 60:979–981.
   PubMed Web of Science ®Google Scholar
• Sogge MR, Griffith JL, Sinar DR, Mayes GR. Lavage to remove enteric-coated aspirin and gastric outlet obstruction. Ann Intern Med 1977; 87:721–722.
   PubMed Web of Science ®Google Scholar
• Sherry E. Pyloric obstruction caused by aspirin: case report. N Z Med J 1979; 89:174–175.
   PubMedGoogle Scholar
• Springer DJ, Groll A. Poisoning with enteric-coated acetylsalicylic acid complicating gastric outlet obstruction. Can Med Assoc J 1980; 122:1032–1034.
   PubMed Web of Science ®Google Scholar
• Halla JT, Fallahi S, Hardin JG. Acute and chronic salicylate intoxication in a patient with gastric outlet obstruction. Arthritis Rheum 1981; 24:1205–1207.
   PubMed Web of Science ®Google Scholar
• Bogacz K, Caldron P. Enteric-coated aspirin bezoar: elevation of serum salicylate level by barium study. Case report and review of medical management. Am J Med 1987; 83:783–786.
   PubMed Web of Science ®Google Scholar
• Savitt DL, Hawkins HH, Roberts JR. The radiopacity of ingested medications. Ann Emerg Med 1987; 16:331–339.
   PubMed Web of Science ®Google Scholar
• Iberti TJ, Patterson BK, Fisher CJ Jr. Prolonged bromide intoxication resulting from a gastric bezoar. Arch Intern Med 1984; 144:402–403.
   PubMed Web of Science ®Google Scholar
• Cohen MI, Winslow PR, Boley SJ. Intestinal obstruction associated with cholestyramine therapy. N Engl J Med 1969; 280:1285–1286.
   PubMed Web of Science ®Google Scholar
• Lapostolle F, Finot MA, Adnet F, Borron SW, Baud FJ, Bismuth C. Radiopacity of clomipramine conglomerations and unsuccessful endoscopy: report of 4 cases. J Toxicol Clin Toxicol 2000; 38:477–482.
   PubMed Web of Science ®Google Scholar
• Hojer J, Personne M. Endoscopic removal of slow release clomipramine bezoars in two cases of acute poisoning. Clin Toxicol (Phila) 2008; 46:317–319.
   PubMed Web of Science ®Google Scholar
• Peterson CD, Fifield GC. Emergency gastrotomy for acute iron poisoning. Ann Emerg Med 1980; 9:262–264.
   PubMed Web of Science ®Google Scholar
• Venturelli J, Kwee Y, Morris N, Cameron G. Gastrotomy in the management of acute iron poisoning. J Pediatr 1982; 100:768–769.
   PubMed Web of Science ®Google Scholar
• Landsman I, Bricker JT, Reid BS, Bloss RS. Emergency gastrotomy: treatment of choice for iron bezoar. J Pediatr Surg 1987; 22:184–185.
   PubMed Web of Science ®Google Scholar
• Foxford R, Goldfrank L. Gastrotomy – a surgical approach to iron overdose. Ann Emerg Med 1985; 14:1223–1226.
   PubMed Web of Science ®Google Scholar
• Bock GW, Tenenbein M. Whole bowel irrigation for iron overdose. Ann Emerg Med 1987; 16:137–138.
   PubMed Web of Science ®Google Scholar
• Tenenbein M. Whole bowel irrigation in iron poisoning. J Pediatr 1987; 111:142–145.
   PubMed Web of Science ®Google Scholar
• Velez LI, Gracia R, Mills LD, Shepherd G, Feng SY. Iron bezoar retained in colon despite 3 days of whole bowel irrigation. J Toxicol Clin Toxicol 2004; 42:653–656.
   PubMed Web of Science ®Google Scholar
• Kaczorowski JM, Wax PM. Five days of whole-bowel irrigation in a case of pediatric iron ingestion. Ann Emerg Med 1996; 27:258–263.
   PubMed Web of Science ®Google Scholar
• Tenenbein M, Wiseman N, Yatscoff RM. Gastrotomy and whole bowel irrigation in iron poisoning. Pediatr Emerg Care 1991; 7:286–288.
   PubMedGoogle Scholar
• Ng HW, Tse ML, Lau FL, Chu W. Endoscopic removal of iron bezoar following acute overdose. Clin Toxicol (Phila) 2008; 46:913–915.
   PubMed Web of Science ®Google Scholar
• Tatekawa Y, Nakatani K, Ishii H, Paku S, Kasamatsu M, Sekiya N, Nakano H. Small bowel obstruction caused by a medication bezoar: report of a case. Surg Today 1996; 26:68–70.
   PubMed Web of Science ®Google Scholar
• Jenis EH, Payne RJ, Goldbaum LR. Acute meprobamate poisoning. A fatal case following a lucid interval. JAMA 1969; 207:361–362.
   PubMed Web of Science ®Google Scholar
• Schwartz HS. Acute meprobamate poisoning with gastrotomy and removal of a drug-containing mass. N Engl J Med 1976; 295:1177–1178.
   PubMed Web of Science ®Google Scholar
• Davis RN, Rettmann JA, Christensen B. Relapsing altered mental status secondary to a meprobamate bezoar. J Trauma 2006; 61:990–991.
   PubMed Web of Science ®Google Scholar
• Eeckhout E, Huyghens L, Loef B, Maes V, Sennesael J. Meprobamate poisoning, hypotension and the Swan-Ganz catheter. Intensive Care Med 1988; 14:437–438.
   PubMed Web of Science ®Google Scholar
• Shepherd MF. Bezoar formed by fragments of extended-release nifedipine tablets. Clin Pharm 1993; 12:849–852.
   PubMedGoogle Scholar
• Stack PE, Patel NR, Young MF, Ferslew KE, Thomas E. Pharmacobezoars – the irony of the antidote: first case report of nifedipine XL bezoar. J Clin Gastroenterol 1994; 19:264–265.
   PubMed Web of Science ®Google Scholar
• Georgopoulos S, Gerdes H. Retention of nifedipine extended release tabs in a patient with a colonic stricture. Am J Gastroenterol 1995; 90:2224–2226.
   PubMed Web of Science ®Google Scholar
• Reid T, Rubins JB, Levine J, DeCelles J, Silvis S. Colonic medication bezoar from extended-release nifedipine and procainamide. Arch Fam Med 1995; 4:715–717.
   PubMedGoogle Scholar
• Smitz S, Bonnet V, Delporte JP. Severe gastrointestinal dysfunction and retention of extended release nifedipine tablets. J Am Geriatr Soc 1998; 46:656–657.
   PubMed Web of Science ®Google Scholar
• Kwon HY, Scott RL, Mulloy JP. Small bowel Procardia XL tablet bezoar mimicking cystic pneumatosis intestinalis. Abdom Imaging 1996; 21:142–144.
   PubMed Web of Science ®Google Scholar
• Taylor JR, Streetman DS, Castle SS. Medication bezoars: a literature review and report of a case. Ann Pharmacother 1998; 32:940–946.
   PubMed Web of Science ®Google Scholar
• Wells CD, Luckritz TC, Rady MY, Zornik JM, Leighton JA, Patel BM. Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine. Pharmacotherapy 2006; 26:1802–1805.
   PubMed Web of Science ®Google Scholar
• Niezabitowski LM, Nguyen BN, Gums JG. Extended-release nifedipine bezoar identified one year after discontinuation. Ann Pharmacother 2000; 34:862–864.
   PubMed Web of Science ®Google Scholar
• Yeen WC, Willis IH. Retention of extended release nifedipine capsules in a patient with enteric stricture causing recurrent small bowel obstruction. South Med J 2005; 98:839–842.
   PubMed Web of Science ®Google Scholar
• Bass DM, Prevo M, Waxman DS. Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS): a retrospective study. Drug Saf 2002; 25:1021–1033.
   PubMed Web of Science ®Google Scholar
• Peeters JW, van der Werf SD. Gastric stenosis after potassium chloride ingestion. Endoscopy 1998; 30:S110.
   PubMed Web of Science ®Google Scholar
• Tecklenburg FW, Thomas NJ, Webb SA, Case C, Habib DM. Pediatric ECMO for severe quinidine cardiotoxicity. Pediatr Emerg Care 1997; 13:111–113.
   PubMed Web of Science ®Google Scholar
• Sherman S, Friedman AP, Berdon WE, Haller JO. Kayexalate: a new cause of neonatal bowel opacification. Radiology 1981; 138:63–64.
   PubMed Web of Science ®Google Scholar
• Menke JA, Stallworth RE, Binstadt DH, Strano AJ, Wallace SE. Medication bezoar in a neonate. Am J Dis Child 1982; 136:72–73.
   PubMedGoogle Scholar
• Metlay LA, Klionsky BA. An unusual gastric bezoar in a newborn: polystyrene resin and Candida albicans. J Pediatr 1983; 102:121–123.
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Hosking M. Complications following oral administration of exchange resins in extremely low-birth-weight infants. Eur J Pediatr 1987; 146:571–574.
   PubMed Web of Science ®Google Scholar
• Koneru P, Kaufman RA, Talati AJ, Jenkins MB, Korones SB. Successful treatment of sodium polystyrene sulfonate bezoars with serial water-soluble contrast enemas. J Perinatol 2003; 23:431–433.
   PubMedGoogle Scholar
• Algozzine GJ, Hill G, Scoggins WG, Marr MA. Sucralfate bezoar. N Engl J Med 1983; 309:1387.
   PubMed Web of Science ®Google Scholar
• Quigley MA, Flicker M, Caldwell EG. Sucralfate bezoar – theory or fact? Am J Gastroenterol 1986; 81:724–725.
   PubMed Web of Science ®Google Scholar
• Anderson W, Weatherstone G, Veal C. Esophageal medication bezoar in a patient receiving enteral feedings and sucralfate. Am J Gastroenterol 1989; 84:205–206.
   PubMed Web of Science ®Google Scholar
• Carrougher JG, Barrilleaux CN. Esophageal bezoars: the sucralith. Crit Care Med 1991; 19:837–839.
   PubMed Web of Science ®Google Scholar
• Krupp KB, Johns P, Troncoso V. Esophageal bezoar formation in a tube-fed patient receiving sucralfate and antacid therapy: a case report. Gastroenterol Nurs 1995; 18:46–48.
   PubMedGoogle Scholar
• Hart RS, Levin B, Gholson CF. Esophageal obstruction caused by sucralfate impaction. Gastrointest Endosc 1989; 35:474–475.
   PubMed Web of Science ®Google Scholar
• Shueke M, Mihas AA. Esophageal bezoar due to sucralfate. Endoscopy 1991; 23:305–306.
   PubMed Web of Science ®Google Scholar
• Strozik KS, Walele AH, Hoffman H. Bezoar in a preterm baby associated with sucralfate. Clin Pediatr (Phila) 1996; 35:423–424.
   PubMed Web of Science ®Google Scholar
• Cereda JM, Scott J, Quigley EM. Endoscopic removal of pharmacobezoar of slow release theophylline. Br Med J (Clin Res Ed) 1986; 293:1143.
   PubMed Web of Science ®Google Scholar
• Smith WDF. Endoscopic removal of a pharmacobezoar of slow release theophylline. Br Med J (Clin Res Ed) 1987; 294:125.
   Google Scholar
• Bernstein G, Jehle D, Bernaski E, et al. Failure of gastric emptying and charcoal administration in fatal sustained-release theophylline overdose: pharmacobezoar formation. Ann Emerg Med 1992; 21:1388–1390.
   PubMed Web of Science ®Google Scholar
• Saeki S, Shimoda T, Sakai H, Soejima Y, Matsuse H, Kohno S. Successful treatment of theophylline toxicity by upper gastrointestinal endoscopy. Respir Med 2003; 97:734–735.
   PubMed Web of Science ®Google Scholar
• Djogovic D, Hudson D, Jacka M. Gastric bezoar following venlafaxine overdose. Clin Toxicol (Phila) 2007; 45:735.
   PubMed Web of Science ®Google Scholar
• Hudson D, Djogovic D. Alternate venlafaxine kinetics in overdose patients. J Clin Pharm Ther 2007; 32:109.
   PubMed Web of Science ®Google Scholar
• Jones JB, Moore JC, Setzer SC, Lintner CP, Roberts DJ. Massive venlafaxine ingestion resulting hypotension and pharmacobezoar formation, in 2009 North American Congress of Clinical Toxicology (NACCT). Clin Toxicol: Phila; 2009; 47:747. Abstracts.
   Google Scholar
• Rankin RJ, Edwards IR. Overdose of sustained release verapamil. N Z Med J 1990; 103:165.
   PubMedGoogle Scholar
• Buckley N, Dawson AH, Howarth D, Whyte IM. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Med J Aust 1993; 158:202–204.
   PubMed Web of Science ®Google Scholar
• Sporer KA, Manning JJ. Massive ingestion of sustained-release verapamil with a concretion and bowel infarction. Ann Emerg Med 1993; 22:603–605.
   PubMed Web of Science ®Google Scholar
• Robert R, Frat JP, Veinstein A, Rouffineau J. Protective effect of medication bezoar after a massive beta-blocker, digoxin, and amitriptyline poisoning. Clin Toxicol (Phila) 2005; 43:381–382.
   PubMed Web of Science ®Google Scholar